Insmed Inc (NASDAQ: INSM) on Monday, plunged -0.34% from the previous trading day, before settling in for the closing price of $68.32. Within the past 52 weeks, INSM’s price has moved between $21.92 and $80.53.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 275.45% over the last five years. The company achieved an average annual earnings per share of 0.19%. With a float of $174.74 million, this company’s outstanding shares have now reached $178.90 million.
The firm has a total of 912 workers. Let’s measure their productivity. In terms of profitability, gross margin is 76.51%, operating margin of -214.11%, and the pretax margin is -251.01%.
Insmed Inc (INSM) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Insmed Inc is 2.33%, while institutional ownership is 101.78%. The most recent insider transaction that took place on Sep 13 ’24, was worth 2,072,223. In this transaction Chief Legal Officer of this company sold 27,871 shares at a rate of $74.35, taking the stock ownership to the 67,856 shares. Before that another transaction happened on Sep 13 ’24, when Company’s Chief Medical Officer sold 26,969 for $74.90, making the entire transaction worth $2,019,978. This insider now owns 106,134 shares in total.
Insmed Inc (INSM) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -1.28 earnings per share (EPS) for the period falling under the consensus outlook (set at -1.15) by -0.13. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.27 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 0.19% per share during the next fiscal year.
Insmed Inc (NASDAQ: INSM) Trading Performance Indicators
Insmed Inc (INSM) is currently performing well based on its current performance indicators. A quick ratio of 5.99 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 36.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.56, a number that is poised to hit -1.16 in the next quarter and is forecasted to reach -4.23 in one year’s time.
Technical Analysis of Insmed Inc (INSM)
Analysing the last 5-days average volume posted by the [Insmed Inc, INSM], we can find that recorded value of 1.58 million was lower than the volume posted last year of 2.27 million. As of the previous 9 days, the stock’s Stochastic %D was 20.15%. Additionally, its Average True Range was 2.25.
During the past 100 days, Insmed Inc’s (INSM) raw stochastic average was set at 36.82%, which indicates a significant increase from 18.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.90% in the past 14 days, which was lower than the 38.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $72.87, while its 200-day Moving Average is $51.49. Now, the first resistance to watch is $69.51. This is followed by the second major resistance level at $70.94. The third major resistance level sits at $72.30. If the price goes on to break the first support level at $66.72, it is likely to go to the next support level at $65.36. Should the price break the second support level, the third support level stands at $63.93.
Insmed Inc (NASDAQ: INSM) Key Stats
Market capitalization of the company is 12.37 billion based on 171,849K outstanding shares. Right now, sales total 305,210 K and income totals -749,570 K. The company made 90,340 K in profit during its latest quarter, and -300,610 K in sales during its previous quarter.
